US3670015A - Ethanecarbonyl-1,2-diphosphonic acid, water-soluble salts thereof and process for preparation - Google Patents
Ethanecarbonyl-1,2-diphosphonic acid, water-soluble salts thereof and process for preparation Download PDFInfo
- Publication number
- US3670015A US3670015A US786428A US3670015DA US3670015A US 3670015 A US3670015 A US 3670015A US 786428 A US786428 A US 786428A US 3670015D A US3670015D A US 3670015DA US 3670015 A US3670015 A US 3670015A
- Authority
- US
- United States
- Prior art keywords
- diphosphonic acid
- hydroxy
- base
- ethanecarbonyl
- diphosphonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 230000008569 process Effects 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims description 14
- 150000003839 salts Chemical class 0.000 title abstract description 27
- 239000002585 base Substances 0.000 claims description 34
- 238000006243 chemical reaction Methods 0.000 claims description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 27
- -1 Alkali metal salts Chemical class 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 11
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 150000007529 inorganic bases Chemical class 0.000 claims description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 239000000908 ammonium hydroxide Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 abstract description 17
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 abstract description 15
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 239000006227 byproduct Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 230000008707 rearrangement Effects 0.000 description 6
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 150000001768 cations Chemical group 0.000 description 5
- 229910052744 lithium Inorganic materials 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical group [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 3
- 238000006704 dehydrohalogenation reaction Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 150000002903 organophosphorus compounds Chemical class 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000000954 titration curve Methods 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 2
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910001413 alkali metal ion Inorganic materials 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- KMPWYEUPVWOPIM-KODHJQJWSA-N cinchonidine Chemical compound C1=CC=C2C([C@H]([C@H]3[N@]4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-KODHJQJWSA-N 0.000 description 2
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- XQRLCLUYWUNEEH-UHFFFAOYSA-N diphosphonic acid Chemical compound OP(=O)OP(O)=O XQRLCLUYWUNEEH-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- BMFVGAAISNGQNM-UHFFFAOYSA-N isopentylamine Chemical compound CC(C)CCN BMFVGAAISNGQNM-UHFFFAOYSA-N 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 125000000466 oxiranyl group Chemical group 0.000 description 2
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- XYORSKKUGAGNPC-UHFFFAOYSA-N phosphonocarbonylphosphonic acid Chemical compound OP(O)(=O)C(=O)P(O)(O)=O XYORSKKUGAGNPC-UHFFFAOYSA-N 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- NDNUANOUGZGEPO-QMMMGPOBSA-N (+)-coniine Chemical compound CCC[C@H]1CCCCN1 NDNUANOUGZGEPO-QMMMGPOBSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 1
- PXJACNDVRNAFHD-UHFFFAOYSA-N (2-methoxyphenyl)methanamine Chemical compound COC1=CC=CC=C1CN PXJACNDVRNAFHD-UHFFFAOYSA-N 0.000 description 1
- CJAAPVQEZPAQNI-UHFFFAOYSA-N (2-methylphenyl)methanamine Chemical compound CC1=CC=CC=C1CN CJAAPVQEZPAQNI-UHFFFAOYSA-N 0.000 description 1
- GRRIMVWABNHKBX-UHFFFAOYSA-N (3-methoxyphenyl)methanamine Chemical compound COC1=CC=CC(CN)=C1 GRRIMVWABNHKBX-UHFFFAOYSA-N 0.000 description 1
- HMTSWYPNXFHGEP-UHFFFAOYSA-N (4-methylphenyl)methanamine Chemical compound CC1=CC=C(CN)C=C1 HMTSWYPNXFHGEP-UHFFFAOYSA-N 0.000 description 1
- WRRSFOZOETZUPG-FFHNEAJVSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;hydrate Chemical compound O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC WRRSFOZOETZUPG-FFHNEAJVSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- IDPURXSQCKYKIJ-UHFFFAOYSA-N 1-(4-methoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 1
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- IIFFFBSAXDNJHX-UHFFFAOYSA-N 2-methyl-n,n-bis(2-methylpropyl)propan-1-amine Chemical compound CC(C)CN(CC(C)C)CC(C)C IIFFFBSAXDNJHX-UHFFFAOYSA-N 0.000 description 1
- NJBCRXCAPCODGX-UHFFFAOYSA-N 2-methyl-n-(2-methylpropyl)propan-1-amine Chemical compound CC(C)CNCC(C)C NJBCRXCAPCODGX-UHFFFAOYSA-N 0.000 description 1
- SPVVMXMTSODFPU-UHFFFAOYSA-N 3-methyl-n-(3-methylbutyl)butan-1-amine Chemical compound CC(C)CCNCCC(C)C SPVVMXMTSODFPU-UHFFFAOYSA-N 0.000 description 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 229930008564 C01BA04 - Sparteine Natural products 0.000 description 1
- HZZDXVXOETXUEY-UHFFFAOYSA-N CC.[Na].[Na] Chemical compound CC.[Na].[Na] HZZDXVXOETXUEY-UHFFFAOYSA-N 0.000 description 1
- AWCRUZMIVIVPCB-UHFFFAOYSA-N CC.[Na].[Na].[Na] Chemical compound CC.[Na].[Na].[Na] AWCRUZMIVIVPCB-UHFFFAOYSA-N 0.000 description 1
- CSDJJFAXVTYZQC-UHFFFAOYSA-N CC.[Na].[Na].[Na].[Na] Chemical compound CC.[Na].[Na].[Na].[Na] CSDJJFAXVTYZQC-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- MBYXEBXZARTUSS-QLWBXOBMSA-N Emetamine Natural products O(C)c1c(OC)cc2c(c(C[C@@H]3[C@H](CC)CN4[C@H](c5c(cc(OC)c(OC)c5)CC4)C3)ncc2)c1 MBYXEBXZARTUSS-QLWBXOBMSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- JZUTXVTYJDCMDU-MOPGFXCFSA-N Hydrastine Chemical compound CN1CCC2=CC=3OCOC=3C=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 JZUTXVTYJDCMDU-MOPGFXCFSA-N 0.000 description 1
- CRAVBINFWZGLSC-UHFFFAOYSA-N Hydrastine Natural products COC1=C(OC)C2C(C=C1)C(OC2=O)C3N(C)CCc4cc5OCOc5cc34 CRAVBINFWZGLSC-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methyl-N-phenylamine Natural products CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- PIJVFDBKTWXHHD-UHFFFAOYSA-N Physostigmine Natural products C12=CC(OC(=O)NC)=CC=C2N(C)C2C1(C)CCN2C PIJVFDBKTWXHHD-UHFFFAOYSA-N 0.000 description 1
- AUVVAXYIELKVAI-UHFFFAOYSA-N SJ000285215 Natural products N1CCC2=CC(OC)=C(OC)C=C2C1CC1CC2C3=CC(OC)=C(OC)C=C3CCN2CC1CC AUVVAXYIELKVAI-UHFFFAOYSA-N 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FVECELJHCSPHKY-WTFKENEKSA-N Veratrine (amorphous) Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)O[C@@H]1[C@]2(O)O[C@@]34C[C@@]5(O)[C@H](CN6[C@@H](CC[C@H](C)C6)[C@@]6(C)O)[C@]6(O)[C@@H](O)C[C@@]5(O)[C@@H]4CC[C@H]2[C@]3(C)CC1 FVECELJHCSPHKY-WTFKENEKSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- JQUQNGYUEFSZBS-UHFFFAOYSA-N [Na].CC Chemical compound [Na].CC JQUQNGYUEFSZBS-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- SLRCCWJSBJZJBV-UHFFFAOYSA-N alpha-isosparteine Natural products C1N2CCCCC2C2CN3CCCCC3C1C2 SLRCCWJSBJZJBV-UHFFFAOYSA-N 0.000 description 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 description 1
- RXVGBQCEAQZMLW-UHFFFAOYSA-N alpha-solanine Natural products CC1CCC2C(C)C3C(CC4C5CC=C6CC(CCC6(C)C5CCC34C)OC7OC(CO)C(O)C(OC8OC(CO)C(O)C(O)C8O)C7OC9OC(CO)C(O)C(O)C9O)N2C1 RXVGBQCEAQZMLW-UHFFFAOYSA-N 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 1
- 229960004046 apomorphine Drugs 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 229910001423 beryllium ion Inorganic materials 0.000 description 1
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 1
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 229910001408 cation oxide Inorganic materials 0.000 description 1
- UWGBIKPRXRSRNM-UHFFFAOYSA-N cevadine Natural products CC=C(C)/C(=O)OC1CCC2(C)C3CCC4C5(O)CC(O)C6(O)C(CN7CC(C)CCC7C6(C)O)C5(O)CC24OCC13O UWGBIKPRXRSRNM-UHFFFAOYSA-N 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Natural products C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 229940077451 coniine Drugs 0.000 description 1
- 229930016881 coniine Natural products 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- JZUTXVTYJDCMDU-UHFFFAOYSA-N d-alpha-hydrastine Natural products CN1CCC2=CC=3OCOC=3C=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 JZUTXVTYJDCMDU-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- KTTMEOWBIWLMSE-UHFFFAOYSA-N diarsenic trioxide Chemical compound O1[As](O2)O[As]3O[As]1O[As]2O3 KTTMEOWBIWLMSE-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- AUVVAXYIELKVAI-CKBKHPSWSA-N emetine Chemical compound N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 description 1
- 229960002694 emetine Drugs 0.000 description 1
- AUVVAXYIELKVAI-UWBTVBNJSA-N emetine Natural products N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@H]1CC AUVVAXYIELKVAI-UWBTVBNJSA-N 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 229930005369 hydrastine Natural products 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- LJOQGZACKSYWCH-WZBLMQSHSA-N hydroquinine Chemical compound C1=C(OC)C=C2C([C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4CC)=CC=NC2=C1 LJOQGZACKSYWCH-WZBLMQSHSA-N 0.000 description 1
- 229960004251 hydroquinine Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- LYBKPDDZTNUNNM-UHFFFAOYSA-N isopropylbenzylamine Chemical compound CC(C)NCC1=CC=CC=C1 LYBKPDDZTNUNNM-UHFFFAOYSA-N 0.000 description 1
- 229910021514 lead(II) hydroxide Inorganic materials 0.000 description 1
- VNZYIVBHUDKWEO-UHFFFAOYSA-L lead(ii) hydroxide Chemical compound [OH-].[OH-].[Pb+2] VNZYIVBHUDKWEO-UHFFFAOYSA-L 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- FQXXSQDCDRQNQE-UHFFFAOYSA-N markiertes Thebain Natural products COC1=CC=C2C(N(CC3)C)CC4=CC=C(OC)C5=C4C23C1O5 FQXXSQDCDRQNQE-UHFFFAOYSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- ZWRDBWDXRLPESY-UHFFFAOYSA-N n-benzyl-n-ethylethanamine Chemical compound CCN(CC)CC1=CC=CC=C1 ZWRDBWDXRLPESY-UHFFFAOYSA-N 0.000 description 1
- GNVRJGIVDSQCOP-UHFFFAOYSA-N n-ethyl-n-methylethanamine Chemical compound CCN(C)CC GNVRJGIVDSQCOP-UHFFFAOYSA-N 0.000 description 1
- QWLISCJHYITNQF-UHFFFAOYSA-N n-methoxy-1-phenylmethanamine Chemical compound CONCC1=CC=CC=C1 QWLISCJHYITNQF-UHFFFAOYSA-N 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- PIJVFDBKTWXHHD-HIFRSBDPSA-N physostigmine Chemical compound C12=CC(OC(=O)NC)=CC=C2N(C)[C@@H]2[C@@]1(C)CCN2C PIJVFDBKTWXHHD-HIFRSBDPSA-N 0.000 description 1
- 229960001697 physostigmine Drugs 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- 229960005141 piperazine Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- NDNUANOUGZGEPO-UHFFFAOYSA-N rac-coniine Natural products CCCC1CCCCN1 NDNUANOUGZGEPO-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- BHRZNVHARXXAHW-UHFFFAOYSA-N sec-butylamine Chemical compound CCC(C)N BHRZNVHARXXAHW-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- UKHWJBVVWVYFEY-UHFFFAOYSA-M silver;hydroxide Chemical class [OH-].[Ag+] UKHWJBVVWVYFEY-UHFFFAOYSA-M 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 229940031352 solanine Drugs 0.000 description 1
- ZGVSETXHNHBTRK-OTYSSXIJSA-N solanine Chemical compound O([C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5N6C[C@@H](C)CC[C@@H]6[C@H]([C@@H]5[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZGVSETXHNHBTRK-OTYSSXIJSA-N 0.000 description 1
- SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 description 1
- 229960001945 sparteine Drugs 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- FQXXSQDCDRQNQE-VMDGZTHMSA-N thebaine Chemical compound C([C@@H](N(CC1)C)C2=CC=C3OC)C4=CC=C(OC)C5=C4[C@@]21[C@H]3O5 FQXXSQDCDRQNQE-VMDGZTHMSA-N 0.000 description 1
- 229930003945 thebaine Natural products 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
- 229910021511 zinc hydroxide Inorganic materials 0.000 description 1
- 229940007718 zinc hydroxide Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
Definitions
- the present invention relates to organo-phosphorus compounds which are ethane carbonyl-1,2-diphosphonates. Members of this new class of compounds are distinguished by being relatively stable l-ketophosphonates. This unique relative stability allows them to be used as valuable intermediates in the preparation of ethane hydroxy triphosphonate builder compounds.
- the compounds of the present invention are prepared by a reaction between haloethane- 1 -hydroxyl l -diphosphonic acid and at least 3 equivalents of a base having a pK,, up to about 10. It is believed that the reaction proceeds through and is made possible by the formation of an intermediate reaction product which is an epoxide reaction product believed to have the formula HC C-P03N82 H PO3N21:
- each M is hydrogen or a cation forming a water-soluble salt.
- M for example, can be sodium, potassium, lithium, ammonium, alkyl amine having one to about four carbons per each alkyl group, or alkanolammonium having one to four carbons per each alkanol group.
- Specific examples of compounds provided by the present invention are: ethane carbonyl-l,2-diphosphonic acid; monosodium ethane carbonyl-l ,2-diphosphonate; disodium ethane carbonyl-1,2-diphosphonate; trisodium ethane carbonyl-l ,2-diphosphonate; tetrasodium ethane carbonyl-1,2- diphosphonate; and the corresponding potassium, lithium and ammonium salts.
- alkylamine compounds such as mono-, di-, and trialkylamines, e.g., di(trimethylamine)ethane carbonyl-l,2-diphosphonate, and mono(diethanolamine)ethane carbonyl-1,2-diphosphonate.
- alkylamine compounds such as mono-, di-, and trialkylamines, e.g., di(trimethylamine)ethane carbonyl-l,2-diphosphonate, and mono(diethanolamine)ethane carbonyl-1,2-diphosphonate.
- tetraalkylammonium ethane carbonyll,2-diphosphonate e.g., tetraethylammonium ethane carbonyll ,2-diphosphonate.
- the compounds of the present invention are especially useful and valuable as starting materials for the preparation of a highly effective class of detergency builder compounds, i.e., ethane-l-hydroxy-l,1,2-triphosphonate.
- ethane-l-hydroxy-l,1,2-triphosphonate Such builders are the subject of U.S. Pat. No. 3,400,148.
- a process for converting the compounds of the present invention to the triphosphonate builder is the subject of a copending, commonly assigned patent application Ser. No. 780,370, filed concurrently herewith by James B. Prentice as Process For Preparation Of Ethane- 1 -I-Iydroxy-l l ,2-Triphosphonates From Ethanecarbonyl Diphosphonates.”
- the process embodiment of the present invention comrises reacting 1 mole of 2-haloethane-l-hydroxyl,ldiphosphonic acid with at least 3 moles of a base having a pK, up to about 10, preferably less than 8, in an aqueous solution.
- the halo-substituent can be chlorine, bromine or fluorine. Chlorine and bromine are preferred.
- the chloro-compound is referred to frequently below as being a representative embodiment of this invention.
- the result of this reaction is a formation of a tetra salt of ethane carbonyl-l,2-diphosphonic acid.
- the specific salt formed is determined by the particular base selected as a reactant. Any base compound can be used which has a pK up to about 10, and preferably less than 8. The base strength appears to be the only limiting factor in the selection of a particular base.
- the base can be an inorganic or organic base compound with inorganic bases being preferred.
- Illustrative inorganic base compounds are sodium, potassium, lithium, calcium, barium, magnesium, ammonium, and silver hydroxides, carbonates, bicarbonates, and acetates, arsenous oxide, lead hydroxide and zinc hydroxide. Preferred are sodium, potassium, lithium and ammonium hydroxides.
- Illustrative organic bases are aconitine, ammonium hydroxide, isoamylamine, aniline, apomorphine, benzylamine, benzidine, brucine, n-butylaminc, iso-butylamine, sec-butylamine, tertbutylamine, caffeine, cinchonidine, cinchonine, cocaine,
- the reaction occurs at a temperature in the range of 20 F. to about 215 F and preferably should be performed in the range of 30 F. to about 215 F.
- this intermediate epoxy compound then undergoes rearrangement by having one of the phosphonate groups migrate to the adjacent carbon atom with an accompanying cleavage of the oxirane ring.
- This is illustrated emperically in the following equation, again using sodium as a representative cation and sodium hydroxide as a base: (The dotted lines show migration pattern.)
- the phosphonate group migrates and the oxirane ring cleaves upon the addition of the third or fourth base cation, e.g., sodium and the like.
- the reaction does produce as its final product an ethane carbonyl-1,2-diphosphonate compound.
- the reaction is very rapid with almost quantitative yields, i.e., on the order of 95-100 percent of the total starting phosphorus as the carbonyl diphosphonate.
- the resulting ethane carbonyl-l,Z-diphosphonate salt is readily converted to a free acid or a partial salt by addition of a strong acid such as HCl, H 80 HNO and the like.
- the salt can also be ion exchanged in any convenient manner such as passing the salt through a cation exchange resin in the 1-1 form.
- reaction is run in an aqueous solution. While there is no need for an additional solvent, one can be used. Aqueous solutions in the range of 2 percent to about 50 percent of haloethane carbonyl diphosphonate and 2 to 50 percent of the base reactant are used. Solid sodium hydroxide can likewise be used as illustrated below.
- This reaction can be seen also to be a dehydrohalogenation of the starting chloroethane-l-hydroxy-l ,l-diphosphonic acid.
- salt formation such as 1 mole of NaCl is compensated for by the addition of an equivalent amount of base.
- a preferred embodiment of the present invention is to add the base to an aqueous solution of the chloroethane-l-hydroxy-l,ldiphosphonic acid. If this order is reversed, the desired reaction still occurs but with a considerable amount of an undesired side product being formed.
- the undesired side product also tends to form when more than four equivalents of the base are added rapidly to an aqueous chloroethane-l-hydroxy-l,ldiphosphonic acid. Consequently the preferred practice is to add the base slowly to an aqueous solution of chloroethane- 1- hydroxyl ,l-diphosphonic acid with good stirring.
- reaction including the rearrangement step takes from a few seconds to about 6 hours.
- the reaction is usually completed within 5 minutes if 4 or more moles of base are added.
- a preferred range in which to practice this process is from a few seconds to about 2% hours.
- a preferred recovery procedure involves practicing the present invention by converting chloroethanel-hydr0xy-l,l-diphosphonic acid to a monosodium salt form by reacting it with an alkali metal ion preferably sodium acetate, sodium hydroxide, sodium oxide, sodium carbonate, or sodium bicarbonate, in the presence of an organic solvent.
- an alkali metal ion preferably sodium acetate, sodium hydroxide, sodium oxide, sodium carbonate, or sodium bicarbonate
- the organic solvent is acetic acid and the alkali is added as sodium acetate.
- This reaction proceeds at a temperature of 30 F. to 300 F. and preferably 50 F. to about 275 F.
- the amount of alkali metal added should be in the range of 0.5 to 1.1 moles of alkali metal ion per mole of chloroethane-lhydroxy-1,1-diphosphonic acid.
- the amount of organic solvent, preferably acetic acid, present is not critical. It serves only as a solvent and can satisfactorily be employed in an amount per mole of chloroethanel-hydroxy-1,I- diphosphonic acid of 3 to about 50 moles of solvent, preferably 6 to moles of solvent per diphosphonic acid.
- the recovered monosodium salt is then reacted with four more equivalents of a suitable base, e.g., sodium hydroxide, and the heretofore-described rearrangement occurs to form the tetrasodium salt of ethane carbonyl-1,2-diphosphonate.
- a suitable base e.g., sodium hydroxide
- the impurities also can be substantially completely avoided by adding the base reactant more slowly or by reducing the total moles of base so that more of the dehydrohalogenation and rearrangement can occur at a lower pH.
- the ethanecarbonyl-l,2- diphosphonic acid compound formed by the foregoing reaction can be crystallized as the fully neutralized salt, e.g., sodium, potassium, ammonium and the like. It is recovered in this way in the form of monohydrate salt or an anhydrous acid.
- the fully neutralized salts are readily precipitated from aqueous solutions as well-formed hydrated crystals.
- the free acid is slower to crystallize but can be obtained as either the monohydrate from concentrated aqueous solutions or as the anhydrous acid crystallized from acetic acid solution.
- the ethanecarbonybl,Z-diphosphonic acid has been found to be stable in aqueous solutions for 2-3 hours at 70 C. At C. after 48 hours, the free acid was completely decomposed.
- EXAMPLE I 1.32 g. (0.005 mole) of the NaI-I salt of chloroethane-lhydroxy-1,l-diphosphonic acid (ClEI-IDP) was dissolved in 2.8 cc. of water and 1.20 cc. (0.015 mole) of 33- weight percent NaOl-l was added slowly with good stirring. An ice bath was applied during addition of the NaOH so that the reaction temperature did not exceed C. The clear aqueous reaction solution on analysis was found to contain 96 percent of the product as ethanecarbonyl-l ,2-diphosphonate (trisodium salt).
- EXAMPLE 11 Same procedure as in Example I was followed except that 1.60 cc. (0.02 mole) of 33- 6 NaOH were used, and 2.40 cc. of water were present to dissolve the chloroethane-l-hydroxy- 1,1-diphosphonate. The clear aqueous reaction solution on analysis was found to contain 71 percent ethanecarbonyl-1,2- diphosphonate (tetrasodium salt) EXAMPLE Ill Same procedure as Example I was followed except that 2.00 cc. (0.025 mole) of 33- 16 NaOI-l were used, and 2.00 cc. of water were present to dissolve the chloroethane-l-hydroxy- 1,1-diphosphonate. The clear aqueous reaction solution on analysis was found to contain 70 percent ethanecarbonyl-1,2- diphosphonate (tetrasodium salt).
- EXAMPLE IV 1.32 g. (.005 mole) of the NaH salt of chloroethane-lhydroxy-l,l-diphosphonic acid was dissolved in 1.32 cc. of water and 2.00 cc. of 12.5 N NaOI-I (0.03 mole) was added with good stirring. An ice bath was used to prevent the solution temperature from exceeding 20 C. The clear solution product was assayed by P MR analysis and found to contain 70 percent ethanecarbonyl-I,2-diphosphonate (tetrasodium salt).
- the starting chloroethane- 1 -hydroxy- 1 1 -diphosphonate reactant used in the present invention can be prepared in any convenient manner. The following demonstration is given by way of example.
- the monoammonium salt of chloroethane-l-hydroxy- 1,1-diphosphonate precipitates on standing, and is subsequently filtered and washed with acetic acid, followed by ethyl ether and dried.
- the yield is about 372 g. or 63 percent of the theoretical chloroethane- 1 -hydroxy-1 1 -diphosphonate (NI-Ll-I salt), monoammonium salt (NI-L11 of chloroethane- 1 -hydroxy-1 l -diphosphonic acid.
- the compounds of the present invention are useful starting materials for the preparation of a valuable class of detergency builders, i.e., ethane-l-hydroxy-l,1,2- triphosphonates.
- U.S. Pat. No. 3,400,148 relates to built detergent compositions in which such triphosphonate compounds are employed as builders.
- the following procedure illustrates the conversion of ethanecarbonyll ,2- diphosphonates (ECnDP) to ethane-l-hydroxy-1,1,2- triphosphonates (EHTP). This procedure is more fully described and exemplified in the aforementioned commonly assigned copending U.S. Pat. application Ser. No. 786,370, concurrently filed by James B.
- the solid was identified as the condensate of ethane-lhydroxy-l,1,2-triphosphonic acid by NMR and by an X-ray diffraction pattern.
- each M is independently selected from the group consisting of hydrogen, sodium, lithium, potassium, ammonium, alkylamine having one to about four carbons per each alkyl group, and alkanolammonium having one to about four carbons per each alkanol group.
- a process for the preparation of ethanecarbonyl-l,2- diphosphonate which comprises reacting a 2-haloethane-1- hydroxy-l,l-diphosphonic acid selected from the group consisting of 2-chloroethane-1-hydroxy-l,l-diphosphonic acid, 2- bromoethane-l-hydroxy-l ,l-diphosphonic acid and 2- fluoroethane-l-hydroxy-1,1-diphosphonic acid with at least 3 mole equivalents of a base having a pK up to about 10 in an aqueous solution at a temperature in the range of from 20 F. to about 215 F.
- reaction temperature is from about 30 F. to about 215 F.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
Abstract
A process for preparing ethane carbonyl-1,2-diphosphonates which comprises reacting 2-haloethane-1-hydroxy-1,1-diphosphonic acid with at least 3 equivalents of a base having a pKb up to about 10. This process yields a salt of ethane carbonyl-1,2diphosphonic acid which can be converted to the free acid.
Description
United States Patent Prentice [451 June 13, 1972 [5 ETHANECARBONYL-l,2-
DIPHOSPHONIC ACID, WATER- SOLUBLE SALTS THEREOF AND PROCESS FOR PREPARATION [72] Inventor: James B. Prentice, Ripley, Ind.
[73] Assignee: The Procter & Gamble Company, Cincinnati, Ohio [22] Filed: Dec. 23, 1968 211 Appl. N6; 786,428
[56] References Cited UNITED STATES PATENTS 3,366,677 1/1968 Quimby ..260/502.4 A 3,400,148 9/1968 Quimby ....260/502.4 A
9/1969 Peck ....260/502.4A 2/1970 Quimby ..260/502.4P
FOREIGN PATENTS OR APPLICATIONS 1,082,235 5/1960 Germany ..260/502.4A 1,102,525 2/1968 Great Britain ..260/502.4A
Primary Examiner-Leon Zitver Assistant ExaminerJoseph E. Evans AttorneyJulius P. Filcik and Richard C. Witte ABSTRACT A process for preparing ethane carbonyl-1,2-diphosphonates which comprises reacting 2-haloethane-l-hydroxy-1,1- diphosphonic acid with at least 3 equivalents of a base having a pK up to about 10. This process yields a salt of ethane carbonyl-1,2-diphosphonic acid which can be converted to the free acid.
9 Claims, No Drawings ETHANECARBONYL- l ,Z-DIPI-IOSPIIONIC ACID, WATER-SOLUBLE SALTS THEREOF AND PROCESS FOR PREPARATION FIELD OF THE INVENTION The present invention relates to organo-phosphorus compounds which are ethane carbonyl-1,2-diphosphonates. Members of this new class of compounds are distinguished by being relatively stable l-ketophosphonates. This unique relative stability allows them to be used as valuable intermediates in the preparation of ethane hydroxy triphosphonate builder compounds.
SUMMARY OF THE INVENTION The compounds of the present invention are prepared by a reaction between haloethane- 1 -hydroxyl l -diphosphonic acid and at least 3 equivalents of a base having a pK,, up to about 10. It is believed that the reaction proceeds through and is made possible by the formation of an intermediate reaction product which is an epoxide reaction product believed to have the formula HC C-P03N82 H PO3N21:
which rearranges to form ethane carbonyl-1,2- diphosphonates.
DETAILED DESCRIPTION This invention pertains to organophosphorus compounds and to a process for their preparation. The compounds have the formula in which each M is hydrogen or a cation forming a water-soluble salt. M, for example, can be sodium, potassium, lithium, ammonium, alkyl amine having one to about four carbons per each alkyl group, or alkanolammonium having one to four carbons per each alkanol group.
Specific examples of compounds provided by the present invention are: ethane carbonyl-l,2-diphosphonic acid; monosodium ethane carbonyl-l ,2-diphosphonate; disodium ethane carbonyl-1,2-diphosphonate; trisodium ethane carbonyl-l ,2-diphosphonate; tetrasodium ethane carbonyl-1,2- diphosphonate; and the corresponding potassium, lithium and ammonium salts. Others are alkylamine compounds such as mono-, di-, and trialkylamines, e.g., di(trimethylamine)ethane carbonyl-l,2-diphosphonate, and mono(diethanolamine)ethane carbonyl-1,2-diphosphonate. Further examples are tetraalkylammonium ethane carbonyll,2-diphosphonate, e.g., tetraethylammonium ethane carbonyll ,2-diphosphonate.
The compounds of the present invention are especially useful and valuable as starting materials for the preparation of a highly effective class of detergency builder compounds, i.e., ethane-l-hydroxy-l,1,2-triphosphonate. Such builders are the subject of U.S. Pat. No. 3,400,148. A process for converting the compounds of the present invention to the triphosphonate builder is the subject of a copending, commonly assigned patent application Ser. No. 780,370, filed concurrently herewith by James B. Prentice as Process For Preparation Of Ethane- 1 -I-Iydroxy-l l ,2-Triphosphonates From Ethanecarbonyl Diphosphonates."
The process embodiment of the present invention comrises reacting 1 mole of 2-haloethane-l-hydroxyl,ldiphosphonic acid with at least 3 moles of a base having a pK, up to about 10, preferably less than 8, in an aqueous solution.
The halo-substituent can be chlorine, bromine or fluorine. Chlorine and bromine are preferred. The chloro-compound is referred to frequently below as being a representative embodiment of this invention. The result of this reaction is a formation of a tetra salt of ethane carbonyl-l,2-diphosphonic acid. The specific salt formed is determined by the particular base selected as a reactant. Any base compound can be used which has a pK up to about 10, and preferably less than 8. The base strength appears to be the only limiting factor in the selection of a particular base. As a result, the base can be an inorganic or organic base compound with inorganic bases being preferred. Illustrative inorganic base compounds are sodium, potassium, lithium, calcium, barium, magnesium, ammonium, and silver hydroxides, carbonates, bicarbonates, and acetates, arsenous oxide, lead hydroxide and zinc hydroxide. Preferred are sodium, potassium, lithium and ammonium hydroxides. Illustrative organic bases are aconitine, ammonium hydroxide, isoamylamine, aniline, apomorphine, benzylamine, benzidine, brucine, n-butylaminc, iso-butylamine, sec-butylamine, tertbutylamine, caffeine, cinchonidine, cinchonine, cocaine,
codeine, coniine, di-iso-amylamine, di-iso-butylamine, diethylamine, diethylbenzylamine, dimethylamine, dimethylaminoantipyrine, dimethylbenzylamine, dipropylamine, emetine, ethanolamine, ethylamine, ethylenediamine, hydrastine, hydrazine, hydroquinine, hydroxylamine, o-methoxybenzylamine, m-methoxybenzylamine, p-methoxybenzylamine, N,N-methoxybenzylamine, methylamine, o-methylbenzylamine, mmethylbenzylamine, p-methylbenzylamine, N,N-methylbenzylamine, methyldiethylamine, morphine, B- naphthylamine, narcotine, nicotine, novocain, papaverine, pphenetidine, e-phenylamylamine, B-phenylbutylamine, o-
phenylenediamine, p-phenylenediamine, B-phenylethylamine, ,B-phenylethyl-methylamine, phenylhydrazine, T-phenylpropylamine, N,N-iso-propylbenzylamine, physostigmine, pilocarpine, piperazine, piperidine, n-propylamine, isopropylamine, pyridine, quinidine, quinine, quinoline, solanine, sparteine, strychnine, tetramethylenediamine, thebaine, otoluidine, m-toluidine, p-toluidine, tri-iso-butylamine, triethylamine, trimethylamine, trimethylenediamine, tripropylamine, and veratrine.
The reaction occurs at a temperature in the range of 20 F. to about 215 F and preferably should be performed in the range of 30 F. to about 215 F.
While the mechanism of the reaction is not fully understood, it is believed that it proceeds through the formation of an intermediate epoxy compound having the following general formula in which sodium has been arbitrarily selected as the cation.
It is believed that this intermediate epoxy compound then undergoes rearrangement by having one of the phosphonate groups migrate to the adjacent carbon atom with an accompanying cleavage of the oxirane ring. This is illustrated emperically in the following equation, again using sodium as a representative cation and sodium hydroxide as a base: (The dotted lines show migration pattern.)
H P OaNaH The rearrangement occurs subsequent to the addition of the second mole equivalent of base. It is fairly certain, however,
that the rearrangement does not begin with the addition of the first or second base cations for these have been noted in a titration curve. Presumably, therefore, the phosphonate group migrates and the oxirane ring cleaves upon the addition of the third or fourth base cation, e.g., sodium and the like.
In any event, it is unexpected that the reaction does produce as its final product an ethane carbonyl-1,2-diphosphonate compound. The reaction is very rapid with almost quantitative yields, i.e., on the order of 95-100 percent of the total starting phosphorus as the carbonyl diphosphonate. The resulting ethane carbonyl-l,Z-diphosphonate salt is readily converted to a free acid or a partial salt by addition of a strong acid such as HCl, H 80 HNO and the like. The salt can also be ion exchanged in any convenient manner such as passing the salt through a cation exchange resin in the 1-1 form.
The reaction is run in an aqueous solution. While there is no need for an additional solvent, one can be used. Aqueous solutions in the range of 2 percent to about 50 percent of haloethane carbonyl diphosphonate and 2 to 50 percent of the base reactant are used. Solid sodium hydroxide can likewise be used as illustrated below.
This reaction can be seen also to be a dehydrohalogenation of the starting chloroethane-l-hydroxy-l ,l-diphosphonic acid. As a result, salt formation such as 1 mole of NaCl is compensated for by the addition of an equivalent amount of base.
A preferred embodiment of the present invention is to add the base to an aqueous solution of the chloroethane-l-hydroxy-l,ldiphosphonic acid. If this order is reversed, the desired reaction still occurs but with a considerable amount of an undesired side product being formed.
To a lesser degree, the undesired side product also tends to form when more than four equivalents of the base are added rapidly to an aqueous chloroethane-l-hydroxy-l,ldiphosphonic acid. Consequently the preferred practice is to add the base slowly to an aqueous solution of chloroethane- 1- hydroxyl ,l-diphosphonic acid with good stirring.
As noted, the reaction including the rearrangement step takes from a few seconds to about 6 hours. The reaction is usually completed within 5 minutes if 4 or more moles of base are added. A preferred range in which to practice this process is from a few seconds to about 2% hours.
It is apparent to one skilled in the art that the addition of the number equivalents of the base can be varied to take into consideration a desired production level or reaction system or technique. Such permissible variations include the use of different bases to partially titrate to a given salt form and then to complete the reaction with a different base.
In this respect, a preferred recovery procedure involves practicing the present invention by converting chloroethanel-hydr0xy-l,l-diphosphonic acid to a monosodium salt form by reacting it with an alkali metal ion preferably sodium acetate, sodium hydroxide, sodium oxide, sodium carbonate, or sodium bicarbonate, in the presence of an organic solvent. Preferably the organic solvent is acetic acid and the alkali is added as sodium acetate. This reaction proceeds at a temperature of 30 F. to 300 F. and preferably 50 F. to about 275 F. The amount of alkali metal added should be in the range of 0.5 to 1.1 moles of alkali metal ion per mole of chloroethane-lhydroxy-1,1-diphosphonic acid. The amount of organic solvent, preferably acetic acid, present is not critical. It serves only as a solvent and can satisfactorily be employed in an amount per mole of chloroethanel-hydroxy-1,I- diphosphonic acid of 3 to about 50 moles of solvent, preferably 6 to moles of solvent per diphosphonic acid. A more detailed description of this separation technique is found in copending US. application Ser. No. 623,21 1 filed Mar. 15, 1967, by Pflaumer et a1. as A Process For Separating Ethanel-Hydroxy-l,l-Diphosphonic Acid From A Solution Of It With Orthophosphoric Acid and now abandoned. The basis for this preferred procedure is the discovery that the monosodium salt crystallized much more rapidly from an organic system than it does from an aqueous system. Thus, a purer product can be obtained by practicing the preferred method rather than by crystallizing the monosodium salt from any aqueous system, although satisfactory results are obtained either way.
The recovered monosodium salt is then reacted with four more equivalents of a suitable base, e.g., sodium hydroxide, and the heretofore-described rearrangement occurs to form the tetrasodium salt of ethane carbonyl-1,2-diphosphonate.
The dehydrohalogenation of the starting chloroethane-lhydroxy -l,1-diphosphonic acid occurs readily in an aqueous base solution. The rate of chlorine removal as HCl is considerably dependent on pH, beginning at about pH 5.5 and increasing with increasing pl-l. If chloroethane-l-hydroxy-l,ldiphosphonic acid was stable at high pH, the expected titration curve would have endpoints at two, three and four equivalents of base. The titration curves which have been obtained, however, reveal that none of the HCl has been removed at the first endpoint (2 equivalents), while all of the HCl has been removed by the time the last endpoint (5 equivalents) is reached. This is true regardless of the rate of titration. The large difference in the amount of base required to reach the second endpoint (3.16 of 4.00 equivalents) demonstrates the lower rate of HCl removal in the near neutral pH range, The removal of HCl from chloroethane-lhydroxy- 1,1-diphosphonic acid has also been substantiated by silver nitrate titration for chloride ion. At the second equivalence point no free chloride ion can be detected while in 1 minute the pH 10, the theoretical amount of chloride ion, is present in aqueous solutions.
Certain by-products can be formed by the present reaction. it has been clearly demonstrated, however, that the migration of the phosphonate group to the alpha carbon to form ethanecarbonyl-l ,Z-diphosphonate (ECnDP) predominates in this system. it is difficult to determine precisely the chemical composition of the reaction by-products. It is known, however, that once they are formed the reaction by-products are stable toward changes in temperature and pH. The possible formation of unknown side product or side products can readily be prevented according to the present invention. One way of accomplishing this is by using concentrated solutions of chloroethane-l-hydroxy-l,l-diphosphonic acid neutralized with sodium hydroxide provided that the number of moles of base is not excessive. The impurities also can be substantially completely avoided by adding the base reactant more slowly or by reducing the total moles of base so that more of the dehydrohalogenation and rearrangement can occur at a lower pH. The ethanecarbonyl-l,2- diphosphonic acid compound formed by the foregoing reaction can be crystallized as the fully neutralized salt, e.g., sodium, potassium, ammonium and the like. It is recovered in this way in the form of monohydrate salt or an anhydrous acid. The fully neutralized salts are readily precipitated from aqueous solutions as well-formed hydrated crystals. The free acid is slower to crystallize but can be obtained as either the monohydrate from concentrated aqueous solutions or as the anhydrous acid crystallized from acetic acid solution. The free ethanecarbonyl-l,2- diphosphonic acid is surprisingly much more stable toward hydrolysis than would be expected judging from the known instability of l-ketophosphonates, as described in Organo- Phosphorus Compounds by G. M. Kasolapofj} Wiley, 1950, page 139.
The ethanecarbonybl,Z-diphosphonic acid has been found to be stable in aqueous solutions for 2-3 hours at 70 C. At C. after 48 hours, the free acid was completely decomposed.
The present invention is more fully illustrated by the following specific examples. These are presented to provide a fuller understanding of the present invention. The present invention is not intended to be limited to the following procedures since numerous variations and modifications thereof will be apparent to those skilled in the art.
Preparation of Ethanecarbonyl-l ,Z-Diphosphonate From Chloroethane- 1 -Hydroxyl l -Diphosphonate In each of the following examples, the solution was analyzed by P MR spectra. The results are given as the percent of the total phosphorus which was in the form of ECnDP, ethane carbonyl-1,2-diphosphonate. In each case most of the remainder was present as an unidentified compound, having a chemical shift of 2 =13.5 ppm in the P MR spectrum (relative to 85% l-I PO reference).
EXAMPLE I 1.32 g. (0.005 mole) of the NaI-I salt of chloroethane-lhydroxy-1,l-diphosphonic acid (ClEI-IDP) was dissolved in 2.8 cc. of water and 1.20 cc. (0.015 mole) of 33- weight percent NaOl-l was added slowly with good stirring. An ice bath was applied during addition of the NaOH so that the reaction temperature did not exceed C. The clear aqueous reaction solution on analysis was found to contain 96 percent of the product as ethanecarbonyl-l ,2-diphosphonate (trisodium salt).
EXAMPLE 11 Same procedure as in Example I was followed except that 1.60 cc. (0.02 mole) of 33- 6 NaOH were used, and 2.40 cc. of water were present to dissolve the chloroethane-l-hydroxy- 1,1-diphosphonate. The clear aqueous reaction solution on analysis was found to contain 71 percent ethanecarbonyl-1,2- diphosphonate (tetrasodium salt) EXAMPLE Ill Same procedure as Example I was followed except that 2.00 cc. (0.025 mole) of 33- 16 NaOI-l were used, and 2.00 cc. of water were present to dissolve the chloroethane-l-hydroxy- 1,1-diphosphonate. The clear aqueous reaction solution on analysis was found to contain 70 percent ethanecarbonyl-1,2- diphosphonate (tetrasodium salt).
EXAMPLE IV 1.32 g. (.005 mole) of the NaH salt of chloroethane-lhydroxy-l,l-diphosphonic acid was dissolved in 1.32 cc. of water and 2.00 cc. of 12.5 N NaOI-I (0.03 mole) was added with good stirring. An ice bath was used to prevent the solution temperature from exceeding 20 C. The clear solution product was assayed by P MR analysis and found to contain 70 percent ethanecarbonyl-I,2-diphosphonate (tetrasodium salt).
EXAMPLE V Same procedure as in Example IV was followed except that 2.87 cc. H O were used to dissolve the chloroethane-lhydroxy-1,1-diphosphonate. Analysis showed the reaction solution to contain 73 percent ethanecarbonyl-l,2- diphosphonate (tetrasodium salt).
EXAMPLE VI Same procedure as in Example IV was followed except that 1 1.85 cc. H O were used to dissolve the chloroethanelhydroxy-l,l-diphosphonate. Analysis showed the reaction solution to contain 81 percent ethanecarbonyl-l,2- diphosphonate (tetrasodium salt).
The starting chloroethane- 1 -hydroxy- 1 1 -diphosphonate reactant used in the present invention can be prepared in any convenient manner. The following demonstration is given by way of example.
Preparation of monoammonium salt of chloroethane-lhydroxy-1,1-diphosphonate Chloroacetic acid (1,250 g., 12 moles), phosphorus acid (147 g., 1.8 moles), and phosphorous trichloride (212 cc., 2.3 moles), are heated to 105 C. over a 2-hour period, and the temperature maintained an additional 2 hours. At this point 200 cc. of water are added, and the temperature maintained at 60 C. for 16 hours. To the clear solution 154 g. NI-I.,OOCCI-I (ammonium acetate) dissolved in 800 cc. of acetic acid is added. The monoammonium salt of chloroethane-l-hydroxy- 1,1-diphosphonate precipitates on standing, and is subsequently filtered and washed with acetic acid, followed by ethyl ether and dried. The yield is about 372 g. or 63 percent of the theoretical chloroethane- 1 -hydroxy-1 1 -diphosphonate (NI-Ll-I salt), monoammonium salt (NI-L11 of chloroethane- 1 -hydroxy-1 l -diphosphonic acid.
As noted above, the compounds of the present invention are useful starting materials for the preparation of a valuable class of detergency builders, i.e., ethane-l-hydroxy-l,1,2- triphosphonates. U.S. Pat. No. 3,400,148 relates to built detergent compositions in which such triphosphonate compounds are employed as builders. The following procedure illustrates the conversion of ethanecarbonyll ,2- diphosphonates (ECnDP) to ethane-l-hydroxy-1,1,2- triphosphonates (EHTP). This procedure is more fully described and exemplified in the aforementioned commonly assigned copending U.S. Pat. application Ser. No. 786,370, concurrently filed by James B. Prentice as Process For Preparation of Ethanel -Hydroxy-1 ,1 ,2-Triphosphonates From Ethanecarbonyl-1,2-Diphosphonates." preparation of ethane-l-hydroxy-l,l,2-triphosphonates from ethanecarbonyll ,Z-diphosphonate The free acid of ethanecarbonyl-1,2-diphosphonatelH 0 (4.46 g; 0.02 mole) was slurried in 18 cc. of Pr SO and PCI;, 1.9 cc.; 0.022 mole) was added at 29 C. The slurry quickly resolved to two liquid phases and the temperature rose to 35 C. The reaction mixture was heated slowly to C. over a l A hour period. The reaction mixture had formed white solids at this point. The slurry was digested for 3 hours at 90 C. then filtered. The solids were washed with ethyl ether and dried under nitrogen. (Yield 6.8 g. of dry solids.)
The solid was identified as the condensate of ethane-lhydroxy-l,1,2-triphosphonic acid by NMR and by an X-ray diffraction pattern.
The foregoing description of the present invention has been presented describing certain operable and preferred embodiments. It is not intended that the invention should be so limited since variations and modifications thereof will be obvious to those skilled in the art, all of which are within the spirit and scope of this invention.
What is claimed is:
1. A compound of the formula in which each M is independently selected from the group consisting of hydrogen, sodium, lithium, potassium, ammonium, alkylamine having one to about four carbons per each alkyl group, and alkanolammonium having one to about four carbons per each alkanol group.
2. Ethanecarbonyl- 1 ,Z-diphosphonic acid.
3. Alkali metal salts of ethanecarbonyl-l,2-diphosphonic acid.
4. A process for the preparation of ethanecarbonyl-l,2- diphosphonate which comprises reacting a 2-haloethane-1- hydroxy-l,l-diphosphonic acid selected from the group consisting of 2-chloroethane-1-hydroxy-l,l-diphosphonic acid, 2- bromoethane-l-hydroxy-l ,l-diphosphonic acid and 2- fluoroethane-l-hydroxy-1,1-diphosphonic acid with at least 3 mole equivalents of a base having a pK up to about 10 in an aqueous solution at a temperature in the range of from 20 F. to about 215 F.
5. A process according to claim 4 in which the reaction temperature is from about 30 F. to about 215 F.
6. A process according to claim 4 in which the 2- haloethane-l-hydroxy-1,1-diphosphonic acid is 2- chloroethane- 1 -hydroxy-1 l-diphosphonic acid.
7. A process according to claim 4 in which the reaction is performed by adding said base to said 2-haloethane-1-hydroxyl 1 -diphosphonic acid.
8. A process according to claim 4 in which said base is an inorganic base.
9. A process according to claim 8 in which the inorganic base is sodium hydroxide, lithium hydroxide, potassium hydroxide or ammonium hydroxide I t t k
Claims (8)
- 2. Ethanecarbonyl-1,2-diphosphonic acid.
- 3. Alkali metal salts of ethanecarbonyl-1,2-diphosphonic acid.
- 4. A process for the preparation of ethanecarbonyl-1,2-diphosphonate which comprises reacting a 2-haloethane-1-hydroxy-1,1-diphosphonic acid selected from the group consisting of 2-chloroethane-1-hydroxy-1,1-diphosphonic acid, 2-bromoethane-1-hydroxy-1,1-diphosphonic acid and 2-fluoRoethane-1-hydroxy-1,1-diphosphonic acid with at least 3 mole equivalents of a base having a pKb up to about 10 in an aqueous solution at a temperature in the range of from 20* F. to about 215* F.
- 5. A process according to claim 4 in which the reaction temperature is from about 30* F. to about 215* F.
- 6. A process according to claim 4 in which the 2-haloethane-1-hydroxy-1,1-diphosphonic acid is 2-chloroethane-1-hydroxy-1,1-diphosphonic acid.
- 7. A process according to claim 4 in which the reaction is performed by adding said base to said 2-haloethane-1-hydroxy-1,1-diphosphonic acid.
- 8. A process according to claim 4 in which said base is an inorganic base.
- 9. A process according to claim 8 in which the inorganic base is sodium hydroxide, lithium hydroxide, potassium hydroxide or ammonium hydroxide.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78642868A | 1968-12-23 | 1968-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3670015A true US3670015A (en) | 1972-06-13 |
Family
ID=25138545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US786428A Expired - Lifetime US3670015A (en) | 1968-12-23 | 1968-12-23 | Ethanecarbonyl-1,2-diphosphonic acid, water-soluble salts thereof and process for preparation |
Country Status (1)
Country | Link |
---|---|
US (1) | US3670015A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3846482A (en) * | 1970-04-13 | 1974-11-05 | Monsanto Co | Substituted ethane diphosphonic acids and salts |
US3940436A (en) * | 1970-04-13 | 1976-02-24 | Monsanto Company | Substituted ethane diphosphonic acids and salts and esters thereof |
US3957858A (en) * | 1970-04-13 | 1976-05-18 | Monsanto Company | Substituted ethane diphosphonic acids and salts and esters thereof |
US3962318A (en) * | 1970-04-13 | 1976-06-08 | Monsanto Company | Substituted ethane diphosphonic acids and salts and esters thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1082235B (en) * | 1958-09-06 | 1960-05-25 | Henkel & Cie Gmbh | Use of organic acylation products of phosphorous acid or its derivatives as complexing agents for metal ions |
US3366677A (en) * | 1965-05-13 | 1968-01-30 | Procter & Gamble | Low temperature preparation of ethane-1-hydroxy-1, 1-diphosphonic acid |
GB1102525A (en) * | 1964-11-11 | 1968-02-07 | Albright & Wilson Mfg Ltd | Improvements in the preparation of organophosphonic acids and their salts |
US3400148A (en) * | 1965-09-23 | 1968-09-03 | Procter & Gamble | Phosphonate compounds |
US3497313A (en) * | 1966-12-29 | 1970-02-24 | Procter & Gamble | Carbonyldiphosphonates |
-
1968
- 1968-12-23 US US786428A patent/US3670015A/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1082235B (en) * | 1958-09-06 | 1960-05-25 | Henkel & Cie Gmbh | Use of organic acylation products of phosphorous acid or its derivatives as complexing agents for metal ions |
GB1102525A (en) * | 1964-11-11 | 1968-02-07 | Albright & Wilson Mfg Ltd | Improvements in the preparation of organophosphonic acids and their salts |
US3468935A (en) * | 1964-11-11 | 1969-09-23 | Albright & Wilson Mfg Ltd | Preparation of organophosphonic acids |
US3366677A (en) * | 1965-05-13 | 1968-01-30 | Procter & Gamble | Low temperature preparation of ethane-1-hydroxy-1, 1-diphosphonic acid |
US3400148A (en) * | 1965-09-23 | 1968-09-03 | Procter & Gamble | Phosphonate compounds |
US3497313A (en) * | 1966-12-29 | 1970-02-24 | Procter & Gamble | Carbonyldiphosphonates |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3846482A (en) * | 1970-04-13 | 1974-11-05 | Monsanto Co | Substituted ethane diphosphonic acids and salts |
US3846483A (en) * | 1970-04-13 | 1974-11-05 | Monsanto Co | Substituted ethane diphosphonic acids and salts and esters thereof |
US3890378A (en) * | 1970-04-13 | 1975-06-17 | Monsanto Co | Substituted ethane diphosphonic acids and salts and esters thereof |
US3940436A (en) * | 1970-04-13 | 1976-02-24 | Monsanto Company | Substituted ethane diphosphonic acids and salts and esters thereof |
US3957858A (en) * | 1970-04-13 | 1976-05-18 | Monsanto Company | Substituted ethane diphosphonic acids and salts and esters thereof |
US3962318A (en) * | 1970-04-13 | 1976-06-08 | Monsanto Company | Substituted ethane diphosphonic acids and salts and esters thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4327039A (en) | Process for the production of 3-amino-1-hydroxypropane-1,1-diphosphonic acid | |
US4083898A (en) | Process for preparing O-aryl, N-phosphonomethylglycinonitriles | |
US3956370A (en) | Preparation of N-phosphonomethylglycine | |
US4053505A (en) | Preparation of n-phosphonomethyl glycine | |
US3366677A (en) | Low temperature preparation of ethane-1-hydroxy-1, 1-diphosphonic acid | |
US3468935A (en) | Preparation of organophosphonic acids | |
EP0085391B1 (en) | Phosphinic acid derivatives and process for preparing the same | |
US3670015A (en) | Ethanecarbonyl-1,2-diphosphonic acid, water-soluble salts thereof and process for preparation | |
US4332746A (en) | Diphosphonodicarboxylic acid esters | |
KR0140090B1 (en) | Process for the continuous preparation of 2-phosphonobutane-1 2,4-tricarboxylic acid and its alkali salts | |
US3476799A (en) | Process for the manufacture of nitrilo-tris-methylene phosphonic acid | |
US5017700A (en) | Preparation of riboflavin-5'-phosphate (5'-FMN) and its sodium salt, and of riboflavin-4',5'-cyclophosphoric acid ester chloride as an intermediate | |
US3658848A (en) | Method for production of ascorbic acid-3-phosphate | |
US3387024A (en) | Class of organo-phosphorous compounds and process for preparing members thereof | |
US3251907A (en) | Method for preparing tetra-secondary alkyl methylenediphosphonates | |
US3032589A (en) | Method of preparing organophosphorus oxides | |
HU200780B (en) | Process for producing n-phosphonomethyl iminodiacetic acid from double salt of iminodiacetic acid | |
US4160779A (en) | Process for the production of methylaminomethylphosphonic acid and its salts | |
US3400151A (en) | Bicyclic dimer of ethane-1-hydroxy-1, 1-diphosphonic acid and salts thereof | |
US3222378A (en) | Phthalimidomethyl phosphorus compounds | |
US3242217A (en) | Organic phosphorus compounds | |
US3374294A (en) | Monoesters of phosphonic acids | |
US3365531A (en) | Monoesters of phosphonic acids | |
HU198947B (en) | Process for producing purin-9-yl-alkoxy-methyl-phosphonic acid derivatives | |
US2899456A (en) | Alkene phosphates |